2953 related articles for article (PubMed ID: 20616235)
1. Long noncoding RNA as modular scaffold of histone modification complexes.
Tsai MC; Manor O; Wan Y; Mosammaparast N; Wang JK; Lan F; Shi Y; Segal E; Chang HY
Science; 2010 Aug; 329(5992):689-93. PubMed ID: 20616235
[TBL] [Abstract][Full Text] [Related]
2. A model for transmission of the H3K27me3 epigenetic mark.
Hansen KH; Bracken AP; Pasini D; Dietrich N; Gehani SS; Monrad A; Rappsilber J; Lerdrup M; Helin K
Nat Cell Biol; 2008 Nov; 10(11):1291-300. PubMed ID: 18931660
[TBL] [Abstract][Full Text] [Related]
3. Role of histone H3 lysine 27 methylation in Polycomb-group silencing.
Cao R; Wang L; Wang H; Xia L; Erdjument-Bromage H; Tempst P; Jones RS; Zhang Y
Science; 2002 Nov; 298(5595):1039-43. PubMed ID: 12351676
[TBL] [Abstract][Full Text] [Related]
4. Regulation of CD11b transcription by decreasing PRC2 and increased acH4 level during ATRA-induced HL-60 differentiation.
Tang H; Chen F; Tan Q; Tan S; Liu L; Zhang F
Acta Biochim Biophys Sin (Shanghai); 2009 Jul; 41(7):588-93. PubMed ID: 19578722
[TBL] [Abstract][Full Text] [Related]
5. Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.
Kirmizis A; Bartley SM; Kuzmichev A; Margueron R; Reinberg D; Green R; Farnham PJ
Genes Dev; 2004 Jul; 18(13):1592-605. PubMed ID: 15231737
[TBL] [Abstract][Full Text] [Related]
6. Binding of different histone marks differentially regulates the activity and specificity of polycomb repressive complex 2 (PRC2).
Xu C; Bian C; Yang W; Galka M; Ouyang H; Chen C; Qiu W; Liu H; Jones AE; MacKenzie F; Pan P; Li SS; Wang H; Min J
Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19266-71. PubMed ID: 20974918
[TBL] [Abstract][Full Text] [Related]
7. Polycomb group protein-associated chromatin is reproduced in post-mitotic G1 phase and is required for S phase progression.
Aoto T; Saitoh N; Sakamoto Y; Watanabe S; Nakao M
J Biol Chem; 2008 Jul; 283(27):18905-15. PubMed ID: 18453536
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of EZH2 by CDK1 and CDK2: a possible regulatory mechanism of transmission of the H3K27me3 epigenetic mark through cell divisions.
Zeng X; Chen S; Huang H
Cell Cycle; 2011 Feb; 10(4):579-83. PubMed ID: 21278485
[TBL] [Abstract][Full Text] [Related]
9. LSD1/CoREST is an allosteric nanoscale clamp regulated by H3-histone-tail molecular recognition.
Baron R; Vellore NA
Proc Natl Acad Sci U S A; 2012 Jul; 109(31):12509-14. PubMed ID: 22802671
[TBL] [Abstract][Full Text] [Related]
10. Vernalization-mediated epigenetic silencing by a long intronic noncoding RNA.
Heo JB; Sung S
Science; 2011 Jan; 331(6013):76-9. PubMed ID: 21127216
[TBL] [Abstract][Full Text] [Related]
11. SFMBT1 functions with LSD1 to regulate expression of canonical histone genes and chromatin-related factors.
Zhang J; Bonasio R; Strino F; Kluger Y; Holloway JK; Modzelewski AJ; Cohen PE; Reinberg D
Genes Dev; 2013 Apr; 27(7):749-66. PubMed ID: 23592795
[TBL] [Abstract][Full Text] [Related]
12. Inner workings and regulatory inputs that control Polycomb repressive complex 2.
O'Meara MM; Simon JA
Chromosoma; 2012 Jun; 121(3):221-34. PubMed ID: 22349693
[TBL] [Abstract][Full Text] [Related]
13. ZNF198 stabilizes the LSD1-CoREST-HDAC1 complex on chromatin through its MYM-type zinc fingers.
Gocke CB; Yu H
PLoS One; 2008 Sep; 3(9):e3255. PubMed ID: 18806873
[TBL] [Abstract][Full Text] [Related]
14. Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes.
Tae S; Karkhanis V; Velasco K; Yaneva M; Erdjument-Bromage H; Tempst P; Sif S
Nucleic Acids Res; 2011 Jul; 39(13):5424-38. PubMed ID: 21447565
[TBL] [Abstract][Full Text] [Related]
15. The malignant brain tumor (MBT) domain protein SFMBT1 is an integral histone reader subunit of the LSD1 demethylase complex for chromatin association and epithelial-to-mesenchymal transition.
Tang M; Shen H; Jin Y; Lin T; Cai Q; Pinard MA; Biswas S; Tran Q; Li G; Shenoy AK; Tongdee E; Lin S; Gu Y; Law BK; Zhou L; Mckenna R; Wu L; Lu J
J Biol Chem; 2013 Sep; 288(38):27680-27691. PubMed ID: 23928305
[TBL] [Abstract][Full Text] [Related]
16. Histone H3 modifications associated with differentiation and long-term culture of mesenchymal adipose stem cells.
Noer A; Lindeman LC; Collas P
Stem Cells Dev; 2009 Jun; 18(5):725-36. PubMed ID: 18771397
[TBL] [Abstract][Full Text] [Related]
17. The polycomb repressive complex 2 is a potential target of SUMO modifications.
Riising EM; Boggio R; Chiocca S; Helin K; Pasini D
PLoS One; 2008 Jul; 3(7):e2704. PubMed ID: 18628979
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA.
Kaneko S; Li G; Son J; Xu CF; Margueron R; Neubert TA; Reinberg D
Genes Dev; 2010 Dec; 24(23):2615-20. PubMed ID: 21123648
[TBL] [Abstract][Full Text] [Related]
19. Role of histone H2A ubiquitination in Polycomb silencing.
Wang H; Wang L; Erdjument-Bromage H; Vidal M; Tempst P; Jones RS; Zhang Y
Nature; 2004 Oct; 431(7010):873-8. PubMed ID: 15386022
[TBL] [Abstract][Full Text] [Related]
20. Histone methylation by PRC2 is inhibited by active chromatin marks.
Schmitges FW; Prusty AB; Faty M; Stützer A; Lingaraju GM; Aiwazian J; Sack R; Hess D; Li L; Zhou S; Bunker RD; Wirth U; Bouwmeester T; Bauer A; Ly-Hartig N; Zhao K; Chan H; Gu J; Gut H; Fischle W; Müller J; Thomä NH
Mol Cell; 2011 May; 42(3):330-41. PubMed ID: 21549310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
